Perflutren (protein-type a microspheres)

Generic Name: perflutren (per-FLOO-tren)
Brand Name: Optison

Serious and sometimes fatal heart and lung problems have occurred uncommonly during and within 30 minutes after administration of perflutren (protein-type a microspheres). Do not use perflutren (protein-type a microspheres) if you have certain heart problems (eg, cardiac shunt). Tell your doctor if you have heart problems (eg, QT prolongation, recent heart attack, serious irregular heartbeat, worsening or unstable heart failure). Tell your doctor if you have lung problems (eg, blood clot in the lungs, high blood pressure in the lungs, respiratory failure, severe emphysema). Your heart function and vital signs will be monitored during and for at least 30 minutes after treatment with perflutren (protein-type a microspheres). Tell your doctor right away if you experience chest, jaw, or arm pain; fainting; fast, slow or irregular heartbeat; seizures; severe headache or dizziness; shortness of breath; sudden, severe nausea or vomiting; trouble breathing; unusual sweating; weakness; or wheezing.


Perflutren (protein-type a microspheres) is used for:

Making the heart easier to see during a certain diagnostic procedure (echocardiogram).

Perflutren (protein-type a microspheres) is a contrast agent. It works in the blood to help create a clearer picture of the heart.

Do NOT use perflutren (protein-type a microspheres) if:

  • you are allergic to any ingredient in perflutren (protein-type a microspheres)
  • you have had an allergic reaction to blood, blood products, or albumin
  • you have certain serious heart problems (eg, cardiac shunt)

Contact your doctor or health care provider right away if any of these apply to you.

Slideshow: Does Your Child Have ADHD? Recognizing Signs & Treatment Options

Before using perflutren (protein-type a microspheres):

  • if you are pregnant, planning to become pregnant, or are breast-feeding
  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
  • if you have allergies to medicines, foods, or other substances
  • if you have a history of lung problems (eg, blood clot in the lungs, high blood pressure in the lungs, respiratory failure, severe emphysema) or heart problems (eg, congenital heart defect, heart attack, heart blood vessel problems, heart failure, irregular heartbeat, QT prolongation)
  • if you have had recent worsening of heart or lung problems

Some MEDICINES MAY INTERACT with perflutren (protein-type a microspheres). However, no specific interactions with perflutren (protein-type a microspheres) are known at this time.

Ask your health care provider if perflutren (protein-type a microspheres) may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use perflutren (protein-type a microspheres):

Use perflutren (protein-type a microspheres) as directed by your doctor. Check the label on the medicine for exact dosing instructions.

  • Perflutren (protein-type a microspheres) will be given as an injection at your doctor's office, hospital, or clinic.
  • Keep this product, as well as syringes and needles, out of the reach of children and away from pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.
  • If you miss a dose of perflutren (protein-type a microspheres), contact your doctor right away.

Ask your health care provider any questions you may have about how to use perflutren (protein-type a microspheres).

Important safety information:

  • Perflutren (protein-type a microspheres) may cause dizziness or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use perflutren (protein-type a microspheres) with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.
  • Perflutren (protein-type a microspheres) contains albumin, which comes from human blood. There is a very rare risk of getting a viral disease or a central nervous system disease called Creutzfeldt-Jakob disease from products with albumin. No cases of these problems have been found in patients who have used perflutren (protein-type a microspheres).
  • Lab tests, including heart function and vital signs, may be performed while you use perflutren (protein-type a microspheres). These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
  • Perflutren (protein-type a microspheres) should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.
  • PREGNANCY and BREAST-FEEDING: If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using perflutren (protein-type a microspheres) while you are pregnant. It is not known if perflutren (protein-type a microspheres) is found in breast milk. If you are or will be breast-feeding while you are using perflutren (protein-type a microspheres), check with your doctor. Discuss any possible risks to your baby.

Possible side effects of perflutren (protein-type a microspheres):

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; headache; nausea; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing or swallowing; tightness in the chest or throat; swelling of the mouth, face, lips, throat, or tongue; unusual hoarseness); blurred vision; burning sensation in the eyes; chest, jaw, or arm pain; decreased feeling in the face; fainting; fast, slow, or irregular heartbeat; fever; flushing; seizure; severe headache or dizziness; shortness of breath; sudden, severe nausea or vomiting; swelling of the hands, ankles, or feet; tremor; unusual sweating; weakness; wheezing.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of perflutren (protein-type a microspheres):

Perflutren (protein-type a microspheres) is handled and stored by a health care provider. Keep perflutren (protein-type a microspheres) out of the reach of children and away from pets.

General information:

  • If you have any questions about perflutren (protein-type a microspheres), please talk with your doctor, pharmacist, or other health care provider.
  • Perflutren (protein-type a microspheres) is to be used only by the patient for whom it is prescribed. Do not share it with other people.
  • If your symptoms do not improve or if they become worse, check with your doctor.
  • Check with your pharmacist about how to dispose of unused medicine.

This information should not be used to decide whether or not to take perflutren (protein-type a microspheres) or any other medicine. Only your health care provider has the knowledge and training to decide which medicines are right for you. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about perflutren (protein-type a microspheres). It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to perflutren (protein-type a microspheres). This information is not specific medical advice and does not replace information you receive from your health care provider. You must talk with your healthcare provider for complete information about the risks and benefits of using perflutren (protein-type a microspheres).

Issue Date: September 3, 2014
Database Edition 14.3.1.003
Copyright © 2014 Wolters Kluwer Health, Inc.

Disclaimer: This information should not be used to decide whether or not to take this medicine or any other medicine. Only your health care provider has the knowledge and training to decide which medicines are right for you. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not specific medical advice and does not replace information you receive from your health care provider. You must talk with your healthcare provider for complete information about the risks and benefits of using this medicine.

Hide
(web5)
Close